Your browser doesn't support javascript.
loading
Desensitization protocol to lenalidomide: An effective and safe treatment modality for delayed hypersensitivity-induced rash in patients with multiple myeloma.
Shamriz, Oded; Parnasa, Elchanan; Rubin, Limor; Talmon, Aviv; Ribak, Yaarit; Lebel, Eyal; Vainstein, Vladimir; Aumann, Shlomzion; Saban, Revital; Gatt, Moshe E; Tal, Yuval.
Afiliação
  • Shamriz O; Allergy and Clinical Immunology Unit, Department of Medicine, Hadassah Medical Organization, Faculty of Medicine, Hebrew University of Jerusalem, Israel.
  • Parnasa E; The Lautenberg Center for Immunology and Cancer Research, Institute of Medical Research Israel-Canada, Faculty of Medicine, Hebrew University of Jerusalem, Israel.
  • Rubin L; Division of Medicine, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Israel.
  • Talmon A; Allergy and Clinical Immunology Unit, Department of Medicine, Hadassah Medical Organization, Faculty of Medicine, Hebrew University of Jerusalem, Israel.
  • Ribak Y; Allergy and Clinical Immunology Unit, Department of Medicine, Hadassah Medical Organization, Faculty of Medicine, Hebrew University of Jerusalem, Israel.
  • Lebel E; Allergy and Clinical Immunology Unit, Department of Medicine, Hadassah Medical Organization, Faculty of Medicine, Hebrew University of Jerusalem, Israel.
  • Vainstein V; Department of Hematology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Israel.
  • Aumann S; Department of Hematology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Israel.
  • Saban R; Department of Hematology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Israel.
  • Gatt ME; Department of Hematology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Israel.
  • Tal Y; Department of Hematology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Israel.
Eur J Haematol ; 110(4): 407-413, 2023 Apr.
Article em En | MEDLINE | ID: mdl-36565290

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article